Virbac SA (VIRB)

Paris
Currency in EUR
308.00
-9.50(-2.99%)
Closed
VIRB Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Unusual trading volume
Fair Value
Day's Range
306.50331.50
52 wk Range
306.00400.00
Key Statistics
Edit
Prev. Close
317.5
Open
312
Day's Range
306.5-331.5
52 wk Range
306-400
Volume
11.57K
Average Volume (3m)
3.77K
1-Year Change
-8.06%
Book Value / Share
118.79
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VIRB Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
394.17
Upside
+27.98%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Virbac Company Profile

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Employees
5459
Market
France

Compare VIRB to Peers and Sector

Metrics to compare
VIRB
Peers
Sector
Relationship
P/E Ratio
18.3x16.4x−0.6x
PEG Ratio
0.950.030.00
Price/Book
2.6x2.2x2.6x
Price / LTM Sales
1.9x2.7x3.1x
Upside (Analyst Target)
26.6%30.3%53.0%
Fair Value Upside
Unlock7.6%8.0%Unlock

Analyst Ratings

6 Buy
3 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 394.17

(+27.98% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 16.84
Dividend Yield
0.43%
Industry Median 3.76%
Annualised payout
1.3200
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 17, 2024
EPS / Forecast
-- / --
Revenue / Forecast
339.20M / 354.20M
EPS Revisions
Last 90 days

People Also Watch

19.94
CBLP
-0.20%
41.10
IPAR
+2.11%
168.60
VU
+1.87%
45.54
ISOS
+2.25%
24.10
VRLA
+7.40%

FAQ

What Is the Virbac (VIRB) Stock Price Today?

The Virbac stock price today is 308.00

What Stock Exchange Does Virbac Trade On?

Virbac is listed and trades on the Paris stock exchange.

What Is the Stock Symbol for Virbac?

The stock symbol for Virbac is "VIRB."

Does Virbac Pay Dividends? What’s The Current Dividend Yield?

The Virbac dividend yield is 0.43%.

What Is the Virbac Market Cap?

As of today, Virbac market cap is 2.58B.

What is Virbac Earnings Per Share?

The Virbac EPS is 16.84.

What Is the Next Virbac Earnings Date?

Virbac will release its next earnings report on 24 Mar 2025.

From a Technical Analysis Perspective, Is VIRB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.